The use of melatonin preparations in sleep disorders
Open Access
- 11 April 2023
- journal article
- research article
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 3,p. 120-124
Abstract
The role in the body and the biological significance of the pineal hormone melatonin is discussed. Data are presented on the effect on biological rhythms in humans and animals, as well as on the sleep in general. In diurnal humans and animals, melatonin acts on the suprachiasmatic nuclei of the hypothalamus to dampen the wake-stimulating signal of the internal clock, thereby promoting sleep. Data are presented on the clinical use of melatonin in sleep disorders: Circadian Rhythm Sleep-Wake Disorders (jet lag syndrome, delayed sleep phase syndrome, irregular cycle), parasomnias (Rapid-Eye Movements Sleep Behavior Disorder) and insomnia. A significant effect of melatonin preparations with a high level of evidence was confirmed in Circadian Rhythm Sleep-Wake Disorders, less pronounced in Parasomnias. The effects of melatonin, used as a drug for jet lag, have the greatest degree of evidence. The melatonin preparation is recommended to be taken both before the flight and at the new place of stay in accordance with the time of its evening secretion in this time zone. In delayed sleep phase syndrome, the onset of melatonin secretion is delayed, reflecting a general lag in the body’s internal clock. Taking melatonin preparations leads to a shift in the sleep-wake cycle to an earlier time. In REM sleep behavior disorder, melatonin preparations to reduce excessive motor activity are preferred over benzodiazepines, since this disorder manifests itself in people of older age groups, and an undesirable effect on cognitive functions should be avoided. In chronic insomnia, the effect of melatonin significantly exceeds the placebo effect and is most pronounced in people of older age groups.Keywords
This publication has 39 references indexed in Scilit:
- Melatonin: Both master clock output and internal time-giver in the circadian clocks networkJournal of Physiology-Paris, 2011
- Melatonin, endocrine pancreas and diabetesJournal of Pineal Research, 2007
- MelatoninThe FEBS Journal, 2006
- The role of melatonin in immuno‐enhancement: potential application in cancerInternational Journal of Experimental Pathology, 2006
- Melatonin and Human RhythmsChronobiology International, 2006
- Sleep deprivation suppresses neurogenesis in the adult hippocampus of ratsEuropean Journal of Neuroscience, 2005
- Melatonin as a local regulator of human placental functionJournal of Pineal Research, 2005
- Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementiaInternational Journal of Geriatric Psychiatry, 2002
- Melatonin at Pharmacologic Doses Increases Bone Mass by Suppressing Resorption Through Down-Regulation of the RANKL-Mediated Osteoclast Formation and ActivationJournal of Bone and Mineral Research, 2002
- Neuroendocrine effects of lightInternational Journal of Biometeorology, 1991